DSN LINK STABLECARRIER WAVE LOCKORBITAL INDEX HOTSIGNAL CLOCK SYNCLOW NOISE FLOORFRAME BUFFER ONLINE
Loading
DSN LINK STABLECARRIER WAVE LOCKORBITAL INDEX HOTSIGNAL CLOCK SYNCLOW NOISE FLOORFRAME BUFFER ONLINE
Loading portal core
55 articles
Stanford scientists are tracing brain aging to a very basic failure: ribosomes, the machines that read genetic instructions and build proteins, begin to stall over time.
A new analysis suggests Alzheimerâs pathology can be detected in midlife brains before dementia and before a dramatic loss of daily function.
Eosinophils are no longer just an allergy footnote: a new review places them among the cells that could help read how tumors respond to immunotherapy.
New molecular clocks do not just estimate how old tissue is; they try to read lifespan itself from patterns of gene activity.
Oura no longer wants to be only a ring for sleep and recovery: according to STAT, it is entering a crowded race to measure blood pressure without a traditional cuff.
Neuroendocrine prostate cancer is a rare, hard and clinically difficult form of the disease, and a new Columbia study now ties it to one clear molecular lever: Sirtuin 1.
A new Vanderbilt Health-led study warns that dementia may not look the same on brain scans across communities, with direct consequences for diagnosis and treatment access.
New MIT work pushes ionotronics from a lab niche toward devices that need to communicate with human tissue without rigid electronics in the middle.
Signsbeat is targeting a gap most wearables still leave open: data can show that the body changed, but rarely explains why.
Xreal xbx are not magic AR glasses that remake computing, but a concrete attempt to package a large private screen into lightweight $299 eyewear.
The FDAâs de novo clearance for Modius is not just another wearable-device headline, but a regulatory signal that neuromodulation is moving deeper into PTSD care.
Early data from a Utah pilot puts AI prescription renewal exactly where it is most sensitive: between routine administration and real clinical responsibility.
The Texas A&M nasal spray sounds like a major medical story, but for now it should be read as a promising preclinical signal, not a ready dementia treatment.
Wearable sensors already measure the body in motion, but without robust data science and clinical validation they remain sophisticated signal sources, not therapeutic instruments.
The SynCell Asia Initiative moves the synthetic cell from grand promise into a harder engineering problem: making life-like modules work as one system.
Type 1 diabetes may not begin as a sudden immune attack, but as a slow beta-cell failure in which viral stress and genetic context reshape the cellsâ defenses.
An AI avatar doctor used before a real oncology appointment could become a practical tool for lowering stress and closing understanding gaps for cancer patients.
In a new analysis, mpox does not behave like an outbreak that can be tracked only through rash, lesions, and patients who know they are sick.
Houston Methodist has used a personalized mRNA vaccine in a patient with osteosarcoma in an attempt to reduce relapse risk under FDA compassionate use.
Researchers at the University of California, Irvine described a wireless, battery-free sensor that continuously tracks multiple sweat biomarkers for 21 days.
Northwestern engineers and clinicians have built a wearable polygraph that tracks five body signals in real time to expose hidden stress, not deception.
A new mouse study suggests that restoring an animal's own youthful gut microbiome can slow biological liver aging and reduce early cancer-linked risk signals.
Researchers using a chronic-itch mouse model found that TRPV4 in sensory neurons helps terminate scratching, pointing to a more precise therapeutic question than simply trying to block itch itself.
Rocket Lab is moving from commercial launch cadence into strategic defense through Raytheonâs Golden Dome work and Andurilâs hypersonic test flights.
University of Illinois researchers demonstrated an MRI framework that measures more than 20 brain biomarkers in one scan.
The University of Queensland produced lead-free indoor perovskite solar cells with 16.36 percent efficiency.
A new preclinical study changes an old assumption: for mRNA vaccines, the key is not only which antigen is delivered, but where the body expresses it.
The discovery focused on excitatory neurons and microglia, revealing disrupted circuits in donated brain tissue from 26 donors with depression.
MIT and Politecnico di Bariâs electrofluidic fibers contract with millisecond precisionâyet their payload capacity maxes out at the weight of a smartphone.
EPFLâs haptic exoskeletons cut violinist timing errors by 30%âprovided the musicians stay within camera range and donât mind the 12ms lag.
Flinders Universityâs *SLEEP* study exposes a blind spot in sleep medicine: patients with erratic night-to-night apnea patterns face 30% higher cardiovascular risk than severity scores alone predict.
Dutch surgeons just turned a 3 a.m. liver transplant into a 9 a.m. oneâwithout harming patient outcomes.
Researchers analyzing 34 countriesâ exposome data pinpointed two distinct drivers of brain aging: social interactions speed cognitive decline, while pollutants erode structural integrity.
Keratinocytes in the epidermis donât just detect threatsâthey broadcast them via a newly identified pathway, Chinese researchers revealed in *Nature Immunology* this week.
Hong Kong researchers engineered a titanium surface that obliterates *Staphylococcus aureus* biofilms in 15 minutesâusing light instead of drugs.
T cellsâimmune systemâs off-meta pickâjust outplayed antibodies in a *Cell Reports* study, targeting viral âcore filesâ instead of mutable cosmetics.
Twenty thousand lab-grown human retinasâeach a cluster of cells no wider than a sesame seedâjust rewrote a key chapter in how cone photoreceptors resist degeneration.
A 2023 *Nature Aging* study analyzing sleep EEGs from 10,000+ adults found subtle brainwave patterns that correlated with accelerated biological aging and future dementia risk.
The FDAâs involvement marks Whoopâs first serious attempt to shift from luxury fitness tracker to medical device.
A 1,700-patient study at the 2024 ESMO Congress found ctDNA detected relapse in triple-negative breast cancer with 85% accuracy.
The hunt for Parkinsonâs disease mechanisms just got a new lead: a cellular âoverflow valveâ that, when broken, may let toxins accumulate.
Denali's Surnazyme treats Hunter syndrome in under 2,000 global patients.
Scientists identify 95% fatality rate for small cell lung cancer patients.
IB101âs defined binding pocket marks a structural advance, but the compound has yet to enter preclinical testing.
BIIB094âs phase 1 trial marks the first time an antisense oligonucleotide has successfully targeted LRRK2 in Parkinsonâs patients.
mRNA cancer vaccines show promise but face years of trialsâprogress isnât the same as proven therapy.
New blood test detects 90% of early-stage pancreatic cancer cases with four-marker panel.
Childhood trauma scars the brainâbut 150+ minutes of weekly exercise may rewire its stress circuits, study finds.
Neuroscientists identify synchronized neuron clustersâengramsâas the likely physical basis of memory, but evidence remains observational and limited to anima...
A recent study published in Nature Medicine has found that a deep learning model using smartwatch data can predict peak oxygen uptake and unplanned healthcare events in patients with heart failure.
Human biomarker study flags overactive brain circuits as a schizophrenia drug targetâbut clinical use remains a decade away.
New method measures cancerâs hidden gene-splicing toolkit, proving tumors weaponize RNA editing to fuel growth and survival.
New method measures cancerâs hidden gene-splicing toolkit, proving tumors weaponize RNA editing to fuel growth and survival.
Ray-Ban Meta glasses are now being tested not just as a gadget, but as a privacy promise that has to survive legal scrutiny.
A new lawsuit alleges Meta contractors reviewed intimate footage users never knew they recorded.
